VistaGen Therapeutics

Illustration for Fierces Chutes Ladders feature showing a blue city skyline with executives making career moves o
Biotech

Neumora shuffles leadership ahead of IND—Chutes & Ladders

Neumora shuffles leadership ahead of IND. Juvena’s new CEO to guide phase 2 neuromuscular studies. Longevica appoints CEO to lead drug development.
Microphone on stage

Double shot of Vistagen’s anxiety nasal spray misses in ph. 2

Aug 6, 2026 10:32am
Goal disorientation and lack of vision

Vistagen fails another phase 3 anxiety trial, spies path forward

Jun 30, 2026 9:48am
Illustration for Fierces Chutes Ladders feature showing a blue city skyline with executives making career moves o

Former FDA leader takes new biotech Turn—Chutes & Ladders

May 22, 2026 8:30am
reducing people on team

Vistagen lays off 20% of staff to focus on anxiety candidate

Mar 12, 2026 1:16pm
dart board miss failure

Vistagen's social anxiety disorder asset stumbles in phase 3

Dec 17, 2025 2:44pm